Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Other funds are buying: https://www.gurufocus.com/news/1336364/lynch--associates-buys-btc-ishares-sp-500-value-etf-fidelity-msci-consumer-discretionary-index-etf-amazoncom-inc-sells-nisource-inc-the-home-depot-inc
*from a different board
GLTU/A.
You bring up a good point. This is probably one of the reasons why the DSMC added the 42 day SE. IMO strictly (and I've studied the science, MOA and did a ton of research), it's a 70/30 with CD12 reaching stat sig at the 28 day mark. The DSMC doesn't just make/add recommendations for shts and giggles. 28 day may not be the data point for us to hit stat sig. Maybe, just maybe CYDY IS waiting on the 42 day mark. Let's see. What I do know is , one way or the other, data is incoming..
GLTU/A.
Excellent DD llh222. Should put a stop to that FUD.
GLTU/A.
kgromax - question for you. Your opinion between SM and NP was of a fiduciary type relationship?
Also, bankers/traders normally use the word 'bips'. Never have I used the word 'base point'.
GLTU/A.
The last word of your post is the achilles heel to anyone that's holding a short position: 'Patience'. Time is NOT on their side. Results will come out. Now they are trying to attack the science (or in this scenario, verbage to the science). Longs know what they own, and TIME is on their side.
GLTU/A.
Spoken like a true wise investor jimmy667. More than enough room for both CYDY, HGEN and some. This virus isn't going ANYWHERE anytime soon.
GLTU/A.
I see. Fair point. I was going off of what we saw historically for the CD10 results + a week or two for the size of the trial and number of participating hospitals. I'd expect at the LATEST, we see something WAY before the end of first quarter.
*EDIT (2). WAIT - I do have a link. Our very own DR at CYDY:
https://www.linkedin.com/posts/nick-agresti-9bb7b473_disruption-of-ccr5-signaling-to-treat-covid-activity-6755669801923825664-rxnG
"Leronlimab is available through emergency individual drug application. Phase 3 double blind placebo controlled trial results out soon."
While the word 'soon' is subjective, I for one hear this as 'a few weeks'.
*Edit (1) - If there was a way to prove out the future, especially during the pandemic and even potential further lockdowns, one would need to be able to literally see the future. I can only estimate what I've seen this company do historically. But even NOW the landscapes changed, right? There's a lot of chatter with multiple, contagious COVID strains, recent news on 400K Amnericans having passed, a new administration that with their agendas which all play into the normal 'business' dynamic. We ARE in a pandemic you know and what used to be, isn't.
GLTU/A.
Good to hear and glad to see you up a lot on all positions.
Lets hope CD12 comes out much better than anyone's wildest expectations.
GLTU/A.
I'm not following you. He said:
"CytoDyn CEO Nader Pourhassan has said: "We believe [Vyrologix] will be an important part of many therapeutics including HIV, cancer and now NASH. We also hope to play a critical role in reducing mortality in patients infected with COVID-19."
Thats EXACTLY what we're expecting to do in a few weeks.
what am I missing?
GLTU/A.
I will be the first one to admit it. All kidding asides. You game to do the same?
GLTU/A.
Lets see if you're right or wrong in a few weeks. Literally binary event here with the unblinding of CD12 (IMHO).
GLTU/A.
cowtown jay - I know you had both feet in HGEN and CYDY. It looks like some not pleasant news on the HGEN front. Hopefully shifted more towards CYDY (seriously curious). I don't think it's extremely bad but end point change cant bode well for SP. Looking forward to CD12 unblinding.
GLTU/A
Great find, thanks for posting.
Very Real post. Best of the this year. Damn well done Chuckles759. Truly.
GLTU/A.
Very very well done and extremely succinct. Thanks Dr Zaius.
This response should help any new comers and or new board posters.
GLTU/A.
Yep, thanks bluefish1. I wanted to give credit where credit is due in terms of acquiring and formatting data (which I haven't verified) by displaying it in a organized manner. Registering 40% conversion of total debt to equity right around the time very close to CD12 unblind and very potential EUA to me, in NP's words, "low risk, high reward".
GLTU/A.
"$10 is the default conversion price.". That's exactly what I stated. $10 conversion price. No tricks or manipulation up my sleeve.
Re-read what you posted:
"But there is a trick. A term called the "full ratchet" term (search for these keyword in the filing). It states the following: should the company sell any share to any investor below the default $10 conversion price, AUTOMATICALLY the conversion price is reduced to this new price. And the number of shares granted to Fife is multiplied by as much, so that Fife makes $21 million in all scenarios. This is an outstanding risk-free deal for Fife (the lender) and the reason these loans are called toxic loans. Let me explain why:
such a sale occured in nov/december, at $3.4 a share. Automatically and WITHOUT ANY LIMIT, Fife got his conversion price reduced to $3.4 a share and his potential shares multiplied by 10/3.4 = nearly x3.
Should the price reach $1 (we were not far during the last november fall), Fife will get x10 times more shares."
Where's the price now? We have unblinding in a few weeks. Everything I posted was fact. Now when someone posts:
"Imagine him dumping today's shares on the tiny OTC market. Millions of them. The bid would implode, not enough liquidity, and you could lose 40-80% of your investment in a couple days. Note: he dumped shares in ALL the deals he made with >20 companies before Cytodyn."
You think someone that owns shares that they JUST converted will blow the bid down to $0? "Fife will get x10 more shares". Buddy, what's 10 x 0?
GLTU/A.
This is a great chart, assuming the data is correct. I can also appreciate the legend you provide and the estimated burn-rate. One thing you obviously couldn't have factored in, which nobody asides CYDY knows, how much revenue that was generated between now and 12/30 with open label that was extended for CD12 patients. That does generate revenue and also will add to the asset-liability=SH equity equation, yes?
While this registration for debt/stock conversion of nearly 40% is merely that, 'registration' for the newer investors and newer persons on the forum, should beg the question: why? And why now?
While I agree that this won't get us Nasdaq in the next few days, we are absolutely heading in the right step. That's one better step towards the goal than in was the day before or the previous week.
Remember, the conversion to equity holds that $10 exercise kicker. 40% of one's holding is not trivial, especially with a $10 floor.
GLTU/A.
Slightly agree. Would put this more towards 80%.
GLTU/A.
Someone just posted that this is just a 'registration' for a sale. THat poster is absolutely right. Why did he do that? The more I think about it, he's "conservatively" registering the stock for a sale. In the S3:
"This prospectus relates to the offer and sale by the selling stockholder identified in this prospectus of up to 2,100,000 shares of our common stock (the “Shares”), consisting of shares of common stock issuable upon conversion, at a conversion price of $10.00 per share, of a convertible note issued to the selling stockholder on November 10, 2020."
2.1mm shares at a conversion price of $10.00 per share. Hang on, we close at $5.20 today. Who'd sell for a loss here??
Wait a second, does that mean potentially the 40% he's registered to convert, Streeterville wants some skin in the CD12 unblinding game thinking these shares will be way north of $10?
Hm, lets chew on this S3. Wait there's also the fact that now we've paid down liabilities. Do we qualify for Nasdaq? Hm.
GLTU/A.
*that 1 number S3/S4 MAKES a huge difference this long weekend. HYUGE.
Also, if he's converted to stock, than that means our owner equity balance must go up(assets - liabilities = equity) as he's converted his debt to equity. Last sentence then still stands regarding Nasdaq.
Again most important thing here is, S3 is better than the S4 1000%.
GLTU/A.
Fife sold less than half. Lets speculate the other way, why didn't he sell all of CYDY ? No one knows but we know he has a business to run and he's picking up a fast nickel than a long dime. Good business practice in my book.
GLTU/A.
You are absolutely right. My mistake!
Name of Selling
Stockholder Shares
Beneficially
Owned
Pre-Offering(1) % Owned
Pre-Offering(2) Common Stock
Offered in this
Offering Number of
Shares
Post-Offering % of Shares
Post-Offering(2)
Streeterville Capital, LLC (3)(4)
5,130,795 * 2,100,000 3,030,795 *
Total
5,130,795 * 2,100,000 3,030,795 *
Thanks for correcting. My inital sentence still stands, much better thanthe S4!
GLTU/A.
Ok, this S3 is 1000% times better than an S4 with the 105b-1 plan. We ARE pre-revenue and we need cash until we get some revenue or OWS money. Not very keen on getting the $9mm from Fife but it is what it is.
Lets just get to the unblinding and everything else will fall into place.
Note to mention, this sale goes towards stock owner equity for a potential uplist..? Hm.
GLTU/A.
LL needed STAT: https://nypost.com/2021/01/15/23-die-in-norway-after-receiving-pfizer-covid-19-vaccine/
If you are one to HAVE to get the vaccine (teacher, nurse, etc) OPT for Moderna's.
GLTU/A.
The DOW and SP500 are down today. I doubt even this remarkable company can go against the market as a whole without any news. Now historically NP has dropped news after hours (though I'm not too sure what he would PR at this point without being fluff) on long weekends. Let's see in a few hours if he follows his trend.
To be totally frank, I'd be pretty livid if I see another 105b-1 S4!
GLTU/A.
I have to say, people that short CYDY stock (naked or not), day or swing trade, really have some balls. For one, Unblinding is imminent so the data/truth will come out. But more so, I recently read that the loan was at 33% on an 8 day borrow.
Talk about playing with fire. There's always money to be made, long or short but depending on which side of the fence you're on -- DAMN that is SOME crazy game to play.
GLTU/A.
WaveSlaveDave - excellent find. Seems the writing is/has been on the wall for Leronlimab and CYDY.
Lets rock and roll.
GLTU/A.
https://newjersey.news12.com/new-jersey-hospitals-participate-in-study-to-use-hiv-drug-to-treat-covid
"Paul says that for many people, Leronlimab can be just as vital as a vaccine."
GLTU/A
Today's SP drop is eerily similar to the one we had a few months ago where we hit near $1.80 and test a bottom that wasn't seen since a year ago. You can see what happened the few weeks after that.
Buy where you can and get ready for something that only happens once in a lifetime with CYDY.
Buckle up everyone.
GLTU/A.
It would have been great to have held on to $5 before any news. Looks like our support has somewhat dissipated. I'm hoping we get some news to bring our jump point after the unblinding to be somewhere $5+.
Let's see if NP can make some magic happen .
GLTU/A.
Hookmeister - I like that: "It took them a few days to grow to their current size."
GLTU/A.
Honestly I have no idea. On the call he said next week, 2 days ago. But they decide to drop the 10-Q early at 8:15AM EST. For a company that's routinely late with their timelines, this one comes out of left field.
I'm trying to come up with scenarios and the only one thats even remotely plausible is that they are trying to time the big reveal with a possible uplist.
That's my take.
GLTU/A.
Exactly. Was just about to post that before our good Dr replied.
Big difference between standard vs gaap and you can claim future proceeds/inventory that way, all depends on how you want to slice it.
Now lets take a step back and figure out WHY they released the 10-Q today vs NP's time table of next week.
Hm..? Why go through all the trouble and speed this up?
One has to wonder.
GLTU/A.
This is all that should matter before our un-blinding in a few days and for the month of January.
"Cash
The Company’s cash position of approximately $29.4 million at November 30, 2020 increased approximately $15.1 million as compared to a balance of approximately $14.3 million at May 31, 2020."
Get it right. It's the 10-Q. Big difference in the letters, 'K' and 'Q'.
GLTU/A.
"That would be well over $100 per share" - I'm more particular to $275 but who's counting.
GLTU/A.
Quite the month to month jump and fairly aggressive.
I'll take it!
GLTU/A
FWIW - here's how I see Jan playing out: The week of the 18th is going to be a big week for longs. We have unblinding in a few days but needs a week or so (from the last time they lock and unblinded CD10) which leads us to the week of the 18th. A nod from the gov't agency can/should come that week (IMHO) or at least a PR that OWS is looking to help fund us. We also have quarterlies due that same week. Once the 10Q is filed with the SEC and see above the $5mm shareholder equities needed, I wouldn't be surprised we see a halt and a temp security issued for Nasdaq uplist come the following week.
By end of January this company and PPS should be in a VERY different place.
GLTU/A.